HealthTap, the doctor Q&A site and mobile app, has closed a $24 million series B round of funding — capital it says it will use to acquire “top talent”, expand its web and mobile offerings, and accelerate growth. The new round, which brings the total raised by the company to $37.9m, was led by Khosla Ventures, while existing investors Mayfield Fund, and Mohr Davidow Ventures also participated.
Meanwhile, Keith Rabois, ex-COO of Square and Khosla partner, will join HealthTap’s board of directors, and Vinod Khosla is to act as an advisor to the startup.
HealthTap’s platform provides health information primarily through its Q&A functionality which connects users to a network of more than 38,000 registered doctors, via both its website and mobile apps — thus offering a sometimes more efficient and cheaper alternative to seeing a doctor face-to-face, and certainly a better alternative than rolling the dice on Google when searching for medical advice.
For the doctors who join HealthTap, the platform provides tools to build an online and real-world reputation — the usual draw for those contributing to a Q&A site — and the potential to attract new patients while also improving the quality of health information online, which is noble in itself.
HealthTap claims that the new financing represents “one of the most substantial series B investments to date in the digital health industry”, and that the company has grown “rapidly over the past year, nearly quadrupling the number of doctors in its network, and serving tens of millions of people worldwide via its web and mobile apps.”
Testimony to this, in March we reported that HealthTap was seeing users ask doctors more than 10 million questions every month and that the site was serving more than 7.5 million monthly unique visitors, with its mobile apps having been downloaded more than 2 million times.